← IRONWOOD PHARMACEUTICALS INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $54.0m | $125.7m | $173.2m | $177.0m | $362.6m | $620.1m | $656.2m | $92.2m | $88.6m | $215.5m | |
| Prepaid Expense and Other Assets, Current | $9.0m | $7.3m | $11.1m | $10.7m | $9.2m | $8.7m | $7.7m | $12.0m | $11.9m | $12.0m | |
| Inventory, Net | $1.1m | $735k | — | $648k | — | — | — | — | — | — | |
| Accounts Receivable, after Allowance for Credit Loss | — | — | — | — | $145.8m | $138.0m | $130.0m | $129.1m | $81.9m | $46.7m | |
| Assets, Current | $380.2m | $311.6m | $266.4m | $306.9m | $495.8m | $745.2m | $780.6m | $233.3m | $182.4m | $274.2m | |
| Property, Plant and Equipment, Net | $20.5m | $17.3m | $17.3m | $12.4m | $8.9m | $7.6m | $6.3m | $5.6m | $4.5m | $3.4m | |
| Goodwill | $785k | $785k | $785k | $785k | — | — | — | — | — | — | |
| Intangible Assets, Net (Excluding Goodwill) | $166.1m | $159.9m | — | — | — | — | — | — | — | — | |
| Operating Lease, Right-of-Use Asset | — | — | — | $17.7m | $16.6m | $15.3m | $14.0m | $12.6m | $11.0m | $9.3m | |
| Other Assets, Noncurrent | $1.5m | $870k | $114k | $5k | $943k | $1.0m | $847k | $3.6m | $5.9m | $4.5m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $933k | $3.2m | $21.0m | $11.3m | $122.4m | $114.0m | $115.5m | $129.1m | $81.9m | $46.7m | |
| Accrued Liabilities, Current | $38.3m | $38.2m | $45.3m | $30.5m | $26.5m | $23.6m | $16.7m | $44.3m | $26.8m | $33.2m | |
| Assets | $709.8m | $605.7m | $332.1m | $402.7m | $559.2m | $1.1b | $1.1b | $471.1m | $350.9m | $396.9m | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $1.1m | $3.1m | $3.1m | $3.1m | $3.1m | $3.2m | $3.3m | |
| Accounts Payable, Current | $17.7m | $16.0m | $18.1m | $4.0m | $661k | $935k | $483k | $7.8m | $2.1m | $2.9m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $22.1m | $20.3m | $18.5m | $16.6m | $14.5m | $12.3m | $9.9m | |
| Liabilities, Current | $91.1m | $66.0m | $119.5m | $40.9m | $32.2m | $161.7m | $25.5m | $276.1m | $38.8m | $242.2m | |
| Other Liabilities, Noncurrent | $8.2m | $5.1m | $2.5m | $734k | $1.8m | $3.5m | $9.8m | $28.4m | $17.1m | $21.6m | |
| Long-term Debt | — | — | — | — | $430.3m | $454.2m | $396.3m | — | — | — | |
| Deferred Tax Liabilities, Net | $28.2m | $15.3m | — | $22.6m | — | — | — | — | — | — | |
| Stockholders’ equity: | |||||||||||
| Common Stock, Value, Issued | $148k | $151k | $154k | $158k | $161k | $162k | $154k | $156k | $160k | $163k | |
| Retained Earnings (Accumulated Deficit) | ($1.2b) | ($1.3b) | ($1.6b) | ($1.6b) | ($1.5b) | ($937.6m) | ($696.4m) | ($1.7b) | ($1.7b) | ($1.7b) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($7k) | ($79k) | — | — | — | — | — | ($3.0m) | $923k | ($1.1m) | |
| Additional Paid in Capital, Common Stock | $1.3b | $1.3b | $1.4b | $1.5b | $1.5b | $1.5b | $1.3b | $1.4b | $1.4b | $1.4b | |
| Stockholders' Equity Attributable to Parent | $66.7m | $9.8m | ($196.4m) | ($93.3m) | $62.6m | $605.9m | $652.4m | ($346.3m) | ($301.3m) | ($261.8m) | |
| Liabilities and Equity | $709.8m | $605.7m | $332.1m | $402.7m | $559.2m | $1.1b | $1.1b | $471.1m | $350.9m | $396.9m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.